Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleTeaching Case Studies

The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET

Jorge Alchammas, Zaid Al-Faham, Yezzin Roumayah and Oliver C.Y. Wong
Journal of Nuclear Medicine Technology September 2016, 44 (3) 210-211; DOI: https://doi.org/10.2967/jnmt.115.165639
Jorge Alchammas
Division of Nuclear Medicine, Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine and Beaumont Health System, Oakland University, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zaid Al-Faham
Division of Nuclear Medicine, Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine and Beaumont Health System, Oakland University, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yezzin Roumayah
Division of Nuclear Medicine, Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine and Beaumont Health System, Oakland University, Royal Oak, Michigan
CNMT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver C.Y. Wong
Division of Nuclear Medicine, Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine and Beaumont Health System, Oakland University, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Although the use of 13N-ammonia and 18F-FDG PET shows great promise as a tool for diagnosing heart involvement in inflammatory diseases, it can be equally powerful for following disease progression and treatment outcome. We describe a case in which 18F-FDG PET was effective in following up the treatment outcome of lupus myocarditis.

  • lupus myocarditis
  • 18F-FDG PET
  • 13N-ammonia

Although uncommon, lupus myocarditis carries a prevalence of 8%–25% (1). The condition is usually diagnosed through a combination of physical examination, electrocardiography and echocardiography. Unfortunately, the findings for lupus myocarditis are nonspecific and are the same as those for some other pathologic processes, such as drug-induced cardiomyopathy (antimalarial drugs, cyclophosphamide, phenothiazines), postpartum cardiomyopathy, and uremia. Under those circumstances, a myocardial biopsy is needed to confirm the cause of myocarditis (2). This case study demonstrates that 18F-FDG PET can be used to evaluate lupus myocarditis.

CASE REPORT

A 21-y-old woman presented with a history of worsening lupus myocarditis. Scanning with 13N-ammonia and 18F-FDG PET was ordered. The patient was instructed to follow a high-fat low-carbohydrate diet the day before undergoing imaging but did not have to fast overnight. One hour after injection of the tracers, multiple metabolic tomographic images of the myocardium were obtained. The rest 13N-ammonia perfusion images demonstrated defects in the basal inferior and basal inferior lateral regions, which also showed a corresponding increase in 18F-FDG uptake consistent with active infiltration of the myocardium (Figs. 1 and 2). The patient began treatment with high-dose prednisone, azathioprine, and colchicine. A follow-up myocardial PET study 3 mo later demonstrated findings similar to those of the prior study, with an ejection fraction of 33% (Figs. 2 and 3). These findings indicate a poor response to treatment. As a result, the patient’s treatment regimen was changed to mycophenolate mofetil (Cellcept; Genentech).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Rest 13N-ammonia perfusion images demonstrating defects in basal inferior region and basal inferior lateral region, with corresponding increase in 18F-FDG uptake.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Stress and rest 13N-ammonia perfusion images demonstrating decreased uptake in basal inferior lateral region, with corresponding increase in 18F-FDG uptake. Both stress and rest images also show severe hypoperfusion extending from mid inferior lateral region to mid inferior region. Lack of correspondingly enhanced 18F-FDG uptake suggests that the finding represents fibrosis or scar formation. HLA = horizontal long axis; SA = short axis; VLA = vertical long axis.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

(A) Rest 13N-ammonia polar plot image before treatment. (B) Rest and stress 13N-ammonia polar plot images after treatment. (C) 18F-FDG polar plot image after treatment.

DISCUSSION

A literature search for common lupus myocarditis findings on 18F-FDG PET yielded no results; thus, it is hoped that this case study will popularize an underutilized diagnostic modality for this rare but devastating disease.

To evaluate for inflammatory processes in the heart, such as cardiac sarcoidosis and lupus myocarditis, 13N-ammonia or 82Rb radiotracers with 18F-FDG can be used (3). Cardiac MRI is a new, noninvasive method that has high spatial resolution; allows evaluation of morphology, function, and tissue characteristics; and requires no radiation (4). PET/MRI combines the strengths of both PET and MRI. PET is a noninvasive imaging technique that can detect active metabolic processes with high sensitivity. Hence, a combination with MRI using gadolinium–diethylenetriamine pentaacetic acid (providing high spatial resolution and lack of radiation exposure) seems reasonable (4). In the absence of coronary artery disease, perfusion defects seen on a PET scan may strongly point to an inflammatory condition such as cardiac sarcoidosis or lupus myocarditis (3). In healthy myocardium, PET images show normal perfusion and normal 18F-FDG uptake. However, inflamed myocardium shows decreased perfusion and increased 18F-FDG uptake (3). In our case, the results indicated a poor response to treatment, which corresponded to the unchanged clinical decline. Therefore, the treatment regimen was changed, and the effectiveness of the new treatment will be monitored by follow-up PET imaging for a few months.

Another option to distinguish between lupus myocarditis and other cardiomyopathies is endomyocardial biopsy.

CONCLUSION

Although the use of 13N-ammonia and 18F-FDG PET scanning shows great promise as a tool for diagnosing heart involvement in inflammatory diseases, it can be equally powerful for following disease progression and treatment outcome. In our case, we demonstrated that 18F-FDG PET can be effectively used to follow up the outcome of treatment for lupus myocarditis.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Footnotes

  • Published online Jan. 14, 2016.

REFERENCES

  1. 1.↵
    1. Apte M,
    2. McGwin G Jr.,
    3. Vilá LM
    . Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). Rheumatology (Oxford). 2008;47:362–367.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Schattner A,
    2. Liang MH
    . The cardiovascular burden of lupus: a complex challenge. Arch Intern Med. 2003;163:1507–1510.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Al-Faham Z,
    2. Jolepalem P,
    3. Wong CO
    . The evaluation of cardiac sacoidosis with 18F-FDG PET scan. J Nucl Med Technol. August 13, 2015 [Epub ahead of print].
  4. 4.↵
    1. Greulich S,
    2. Ferreira VM,
    3. Dall’Armellina E,
    4. Mahrholdt H
    . Myocardial inflammation: are we there yet? Curr Cardiovasc Imaging Rep. 2015;8:6.
    OpenUrlCrossRefPubMed
  • Received for publication August 16, 2015.
  • Accepted for publication November 10, 2015.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 44 (3)
Journal of Nuclear Medicine Technology
Vol. 44, Issue 3
September 1, 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET
Jorge Alchammas, Zaid Al-Faham, Yezzin Roumayah, Oliver C.Y. Wong
Journal of Nuclear Medicine Technology Sep 2016, 44 (3) 210-211; DOI: 10.2967/jnmt.115.165639

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET
Jorge Alchammas, Zaid Al-Faham, Yezzin Roumayah, Oliver C.Y. Wong
Journal of Nuclear Medicine Technology Sep 2016, 44 (3) 210-211; DOI: 10.2967/jnmt.115.165639
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-Sensitivity Troponin Elevation in a Young Woman with Typical Chest Pain: The Heart of the Matter
  • Prominent Right Ventricular Tracer Uptake: A Harbinger of Multivessel Coronary Artery Disease
  • SPECT/CT for Discrimination Between Active and Inactive Os Trigonum in Posterior Ankle Syndrome
Show more Teaching Case Studies

Similar Articles

Keywords

  • Lupus Myocarditis
  • 18F-FDG PET
  • 13N-ammonia
SNMMI

© 2025 SNMMI

Powered by HighWire